Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018)
Senseonics Holdings' (SENS) quarterly Current Deferred Revenue came in at $628000.0 in Q4 2018, up 6877.78% on a QoQ basis from $9000.0 in Q1 2016.
Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018) Analysis & Trends
Senseonics Holdings (SENS) has 3 years of Current Deferred Revenue data on file, last reported at $628000.0 in Q4 2018.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $628000.0 in Q4 2018; TTM through Dec 2018 was $628000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $628000.0, changed N/A from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $628000.0, up from $9000.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for SENS reached as high as $628000.0 in Q4 2018 and fell as low as $7000.0 in Q4 2015.
- Historically, Current Deferred Revenue has averaged $214666.7 across 3 years, with a median of $9000.0 in 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 628,000.00 |
| Mar 31, 2016 | 9,000.00 |
| Dec 31, 2015 | 7,000.00 |